In Vivo Molecular Photoacoustic Tomography of Melanomas Targeted by Bioconjugated Gold Nanocages
Citations Over TimeTop 1% of 2010 papers
Abstract
Early diagnosis, accurate staging, and image-guided resection of melanomas remain crucial clinical objectives for improving patient survival and treatment outcomes. Conventional techniques cannot meet this demand because of the low sensitivity, low specificity, poor spatial resolution, shallow penetration, and/or ionizing radiation. Here we overcome such limitations by combining high-resolution photoacoustic tomography (PAT) with extraordinarily optical absorbing gold nanocages (AuNCs). When bioconjugated with [Nle(4),D-Phe(7)]-alpha-melanocyte-stimulating hormone, the AuNCs can serve as a novel contrast agent for in vivo molecular PAT of melanomas with both exquisite sensitivity and high specificity. The bioconjugated AuNCs enhanced contrast approximately 300% more than the control, PEGylated AuNCs. The in vivo PAT quantification of the amount of AuNCs accumulated in melanomas was further validated with inductively coupled plasma mass spectrometry (ICP-MS).
Related Papers
- → Self-Assembly of Responsive Multilayered DNA Nanocages(2015)101 cited
- → Chemically coupled NiCoS/C nanocages as efficient electrocatalysts for nitrogen reduction reactions(2019)67 cited
- → Hollow Boron Nitride (BN) Nanocages and BN‐Nanocage‐Encapsulated Nanocrystals(2004)59 cited
- → Thin-walled graphitic nanocages with nitrogen-doping as superior performance anodes for lithium-ion batteries(2016)20 cited
- → Gold Nanocages: A Multifunctional Platform for Molecular Optical Imaging and Photothermal Treatment(2011)1 cited